Vector-borne diseases (VBDs) represent a significant public health concern in India, with a substantial impact on morbidity and mortality rates. This review aims to provide healthcare professionals with an understanding of the prevalence and impact of these diseases.
India, with its diverse ecological conditions, has a high prevalence of VBDs. Malaria, dengue, and chikungunya are the most commonly reported. Malaria alone accounts for 89% of the South-East Asia region's cases, with India bearing the brunt. Dengue, with its rapid urban spread, has seen a 200% increase in the last decade.
VBDs have a profound impact on India's health and economic stability. They strain the healthcare system, cause work loss, and often lead to high out-of-pocket expenses for families. The World Bank estimates that malaria's economic burden in India is approximately $1.94 billion annually.
Efforts to control VBDs in India face numerous challenges. These include inadequate surveillance, lack of public awareness, and climate change, which can expand vector habitats. Moreover, the rapid urbanization and population growth exacerbate these problems.
Healthcare professionals play a critical role in managing VBDs. Their responsibilities range from early diagnosis and treatment to patient education and community outreach. They are also integral to research efforts aimed at developing more effective prevention and control strategies.
In conclusion, VBDs pose a significant threat to India's public health. Understanding their prevalence and impact is crucial for healthcare professionals, as they are on the front lines of detection, management, and prevention. Continued research, surveillance, and education are vital to mitigate the burden of these diseases.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation